drugset / Trial / NCT00319215

Effects of Ramelteon on Driving Ability

NCT00319215 ↗

RandomizedCrossoverDouble-blindPrevention

Summary

The primary purpose of this study is to investigate the effects of bedtime administration of a single dose of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on next-morning on-road driving performance. In addition, the drugs' effects on balance are evaluated during the night, and the next morning residual effects on memory and psychomotor performance.

Timeline

Start
2006-03
Primary completion
—
Completion
2006-07

Outcome

Missed primary endpoint

paper SDLP was significantly increased after the intake of ramelteon (+2.2 cm) and zopiclone (+2.9 cm). PMID 21966064 ↗

paper Ramelteon (8 mg) and zopiclone (7.5 mg) significantly impaired driving performance, cognitive, memory, and psychomotor performance the morning following bedtime administration. PMID 21966064 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg —
Subject Zopiclone Small molecule 7.5 mg —

Indications